NCT05460598

Brief Summary

This single-blinded (only patients blinded) study is to assess the effect of cooling beddings on itch. The primary objective is to test whether or not the use of the cooling beddings during 3 days can add at least 20% improvement in (nocturnal) itch as measured by the 0-10 NRS in comparison to a control group that does not use the cooling beddings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 15, 2022

Completed
17 days until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2023

Completed
Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

10 months

First QC Date

July 4, 2022

Last Update Submit

August 13, 2024

Conditions

Keywords

cooling beddingssleep qualityscratchingitch reductionitch; nocturnal

Outcome Measures

Primary Outcomes (1)

  • improvement in (nocturnal) itch

    improvement in (nocturnal) itch as measured by the 0-10 Numeric rating Scale (NRS) (at least 2 NRS points per 24 hours to obtain a meaningful therapeutic benefit). (NRS, 0= no itch, 10= worst imaginable)

    NRS ratings will be assessed every 6 hours (throughout 72 hours)

Secondary Outcomes (6)

  • Scratching activity measured by actigraph (Actigraph qGT3X-BT) on the dominant wrist

    Continuously recorded throughout 72 hours

  • Richards-Campbell-Sleep Questionnaire (RCSQ) after each of the three nights addressing the sleep quality

    Assessment after each night (3 times, altogether 72 hours)

  • Patient questionnaire (regarding lying comfort, cooling pleasantness)

    One time assessment after the third night

  • Patient questionnaire regarding cooling intensity

    One time assessment after the third night

  • Staff questionnaire regarding time practicability

    Assessment after staff shift (3 times, altogether 72 hours)

  • +1 more secondary outcomes

Study Arms (2)

interventional group: beddings with cooling effects

ACTIVE COMPARATOR

Cooling beddings: linen made of the Outlast Technology https://www.outlast.com/en/. This product is made of 100 % lyocell and utilizes phase change materials based on natural wax. When this phase change material melts, heat is extracted from the environment and stored in microcapsules called thermocules. When the body cools down, these thermocules harden again release the heat from the linen. This might help to balances the body temperature and prevent warmth-aggravated itch. \- The mattress is made of polyurethane foam and designed as a "cool gel" topper to be placed onto the standard hospital mattress. Heat is also absorbed and stored into this topper. This topper is covered with an Obatex cover. It protects the "cool gel" topper from moisture and organic liquids and is made of polyamide fabric.

Other: beddings with cooling effects

control group: commonly used bedding

PLACEBO COMPARATOR
Other: commonly used bedding

Interventions

beddings with cooling effects (mattress topper and bed linen)

interventional group: beddings with cooling effects

commonly used bedding

control group: commonly used bedding

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mean itch intensity NRS \> 5 in the past 3 days
  • Literacy and ability to read
  • Inpatient stay required for \> 3 nights

You may not qualify if:

  • Age \< 18 years
  • Illiteracy
  • The duration of the hospitalisation is foreseen to be shorter than 3 days
  • Para- and Tetraplegia
  • Hemisensory syndrome
  • Core body temperature \>38°C
  • Use of other bedding \> 8 hours or 2nd time request
  • Use of an occlusive therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Dermatology, University Hospital Basel

Basel, 4031, Switzerland

Location

MeSH Terms

Conditions

PruritusSleep Initiation and Maintenance Disorders

Interventions

Bedding and Linens

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesSkin ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Equipment and Supplies, HospitalEquipment and SuppliesHousehold ArticlesTechnology, Industry, and Agriculture

Study Officials

  • Simon Mueller, PD Dr. med.

    Department of Dermatology, University Hospital Basel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
single-blinded (only patients blinded)
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Single-center, investigator-initiated, single-blinded, interventional, exploratory study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2022

First Posted

July 15, 2022

Study Start

August 1, 2022

Primary Completion

May 28, 2023

Study Completion

May 28, 2023

Last Updated

August 15, 2024

Record last verified: 2024-08

Locations